 | Up a level |
Number of items: 2.
Ireland, L, Santos, A, Ahmed, MS 
ORCID: 0000-0001-6163-8102, Rainer, C, Nielsen, SR, Quaranta, V, Weyer-Czernilofsky, U, Engle, DD, Perez-Mancera, P, Coupland, SE ORCID: 0000-0002-1464-2069 et al (show 6 more authors)
(2016)
Chemoresistance in Pancreatic Cancer Is Driven by Stroma-Derived Insulin-Like Growth Factors.
Cancer Research, 76 (23).
pp. 6851-6863.
Williams, D, Gana, T, Sivapalan, L, Butler, O, Jackson, R, Perez-Mancera, P, Barrera-Briceno, L, Copple, I, Cox, T, Goldring, C et al (show 7 more authors)
(2017)
Nrf2 in Pancreatic Cancer Chemotherapy Response and the Use of Brusatol as a Chemotherapeutic Agent.
.